Literature DB >> 12874889

Progress toward a global understanding of infective endocarditis. Lessons from the International Collaboration on Endocarditis.

Christopher H Cabell1, Elias Abrutyn.   

Abstract

In the century and a quarter since William Osler delivered his famed Gulstonian lectures on endocarditis, continual advancements have been made in understanding and treating this disease. Here we have reviewed some key aspects of current knowledge in the areas of population epidemiology, host factors, microorganisms, and diagnosis. The advent of the ICE investigation provides the opportunity to further expand our understanding of IE by developing a very large, global database of IE patients whose clinical, echocardiographic, and microbiologic findings have been characterized with standard methodology. Further, ICE may serve as a rich source of material for investigators seeking to perform specific studies. Finally, the ICE infrastructure creates the opportunity for performing randomized trials to test therapeutic strategies. Although many obstacles remain to be overcome, ICE has created the opportunity for a quantum leap in our knowledge of IE over the next 25 years.

Entities:  

Mesh:

Year:  2003        PMID: 12874889     DOI: 10.1016/s0733-8651(03)00033-x

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  9 in total

1.  The changing face of infective endocarditis.

Authors:  E Cecchi; M Imazio; R Trinchero
Journal:  Heart       Date:  2006-10       Impact factor: 5.994

Review 2.  Infective endocarditis.

Authors:  Rhys P Beynon; V K Bahl; Bernard D Prendergast
Journal:  BMJ       Date:  2006-08-12

Review 3.  Infective endocarditis: a comparison of international guidelines.

Authors:  Francois Delahaye; Joyce Wong; Peter G Mills
Journal:  Heart       Date:  2007-04       Impact factor: 5.994

4.  Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.

Authors:  Todd Kiefer; Lawrence Park; Christophe Tribouilloy; Claudia Cortes; Roberta Casillo; Vivian Chu; Francois Delahaye; Emanuele Durante-Mangoni; Jameela Edathodu; Carlos Falces; Mateja Logar; José M Miró; Christophe Naber; Marie Françoise Tripodi; David R Murdoch; Philippe Moreillon; Riccardo Utili; Andrew Wang
Journal:  JAMA       Date:  2011-11-23       Impact factor: 56.272

Review 5.  The changing face of infective endocarditis.

Authors:  B D Prendergast
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

6.  Surgical treatment of isolated right-sided infective endocarditis.

Authors:  Sheng-li Jiang; Bo-jun Li; Tao Zhang; Chong-lei Ren; Yao Wang; Ting-ting Chen; Chang-qing Gao
Journal:  Tex Heart Inst J       Date:  2011

7.  Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias.

Authors:  Tahaniyat Lalani; Christopher H Cabell; Daniel K Benjamin; Ovidiu Lasca; Christoph Naber; Vance G Fowler; G Ralph Corey; Vivian H Chu; Michael Fenely; Orathai Pachirat; Ru-San Tan; Richard Watkin; Adina Ionac; Asuncion Moreno; Carlos A Mestres; José Casabé; Natalia Chipigina; Damon P Eisen; Denis Spelman; Francois Delahaye; Gail Peterson; Lars Olaison; Andrew Wang
Journal:  Circulation       Date:  2010-02-16       Impact factor: 29.690

8.  Clinical Characteristics and In-Hospital Prognosis of Infective Endocarditis in Two Eastern Counties of Taiwan.

Authors:  Jen-Che Hsieh; Ling-Yi Wang; Huai-Ren Chang; Shen-Feng Chao; Ji-Hung Wang
Journal:  Acta Cardiol Sin       Date:  2014-03       Impact factor: 2.672

9.  Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study.

Authors:  Patricia Muñoz; Martha Kestler; Arístides De Alarcon; José María Miro; Javier Bermejo; Hugo Rodríguez-Abella; Maria Carmen Fariñas; Manuel Cobo Belaustegui; Carlos Mestres; Pedro Llinares; Miguel Goenaga; Enrique Navas; José Antonio Oteo; Paola Tarabini; Emilio Bouza
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.